Planning Strategies’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
Other funds holding ELDN
AIC
Planning Strategies's ELDN Position: Q3 2026 in Review
Planning Strategies held its Eledon Pharmaceuticals (ELDN) position steady in Q3 2026 at 181 shares worth $458. The position accounts for ﹤0.01% of the portfolio, ranked #948.
Planning Strategies first reported a position in ELDN in Q2 2026 and has held it in 2 quarters since. The position peaked at $713 in Q2 2026. 127 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.
- Planning Strategies held 181 shares of Eledon Pharmaceuticals worth $458 as of Q3 2026.
- Planning Strategies left its Eledon Pharmaceuticals share count unchanged in Q3 2026.
- Eledon Pharmaceuticals made up ﹤0.01% of Planning Strategies's portfolio in Q3 2026, its #948 holding.
- Planning Strategies first reported a position in Eledon Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- Planning Strategies's Eledon Pharmaceuticals position peaked at $713 in Q2 2026.
- 127 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.
Based on Planning Strategies's 13F filing for Q3 2026, filed 2 Oct 2026.